Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-637-2 | CAS number: 68603-75-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 1981-05-11 to 1981-06-12
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: 2b: Comparable to guideline study with acceptable restrictions (no control group is mentioned, no positive control is included).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 1-({3-[(2-hydroxypropyl)[(9E)-octadec-9-en-1-yl]amino]propyl}amino)propan-2-ol; 1-({3-[(2-hydroxypropyl)amino]propyl}(octadecyl)amino)propan-2-ol; 1-({3-[hexadecyl(2-hydroxypropyl)amino]propyl}amino)propan-2-ol
- EC Number:
- 614-637-2
- Cas Number:
- 68603-75-8
- Molecular formula:
- R-N(CH2CHOHCH3)xCH2CH2CH2N(CH2CHOHCH3)y with x+y=3 and where R = alkyl
- IUPAC Name:
- 1-({3-[(2-hydroxypropyl)[(9E)-octadec-9-en-1-yl]amino]propyl}amino)propan-2-ol; 1-({3-[(2-hydroxypropyl)amino]propyl}(octadecyl)amino)propan-2-ol; 1-({3-[hexadecyl(2-hydroxypropyl)amino]propyl}amino)propan-2-ol
- Details on test material:
- - Name of test material (as cited in study report): DINORAM SL
- Physical state: dark brown liquid
- Lot/batch No.: 2884
No other data available
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Shamrock Farms (U.K.)
- Age at study initiation: approximately 2 months
- Weight at study initiation: 322 ± 13 g (males) + 337 ± 10 g (females)
- Housing: polycarbonate cages. 2 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 25°C
- Humidity (%): 50 ± 20 %
- Air changes (per hr): 8
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: olive oil
- Concentration / amount:
- - Induction :
* intradermal injections : test item at the concentration of 0.1% (w/w) in sterile olive oil
* topical application : test item at the concentration of 1% (w/w) in sterile olive oil
- Challenge :
topical application : test item at the concentration of 1% (w/w) in olive oil
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: olive oil
- Concentration / amount:
- - Induction :
* intradermal injections : test item at the concentration of 0.1% (w/w) in sterile olive oil
* topical application : test item at the concentration of 1% (w/w) in sterile olive oil
- Challenge :
topical application : test item at the concentration of 1% (w/w) in olive oil
- No. of animals per dose:
- Treated group : 20 animals ( 10 males and 10 females)
Controls: no data - Details on study design:
- RANGE FINDING TESTS:
For both the preliminary test and the main test, the application sites of all animals were:
• shaved 24 hours before any treatment
Concentrations tested in the range finding test:
By intradermal route (tested concentrations: 100 %, 10%, 5 %, 1% and 0.1% (w/w)):
• intradermal injections of the dosage form preparations (0.1 mL) were performed in the
interscapular region,
• cutaneous reactions were evaluated 24 hours after the injections.
By cutaneous route
Under the conditions of the induction phase (tested concentrations: 100%, 50%, 10%, 1% (w/w)):
• a gauze pad (approximately 4 cm2) was fully-loaded with a dosage form preparation and was
then applied to the shaved area of the skin. The gauze pad was held in place by means of an
occlusive dressing for 24 hours,
• cutaneous reactions were evaluated 1 hour after removal of the dressing.
Under the conditions of the challenge phase (tested concentrations: 100%, 50%, 10% and 1 % (w/w)):
•a gauze pad (approximately 4 cm2) was fully-loaded with a dosage form preparation and was
then applied to the shaved area of the skin. The gauze pad was held in place by means of an
occlusive dressing for 24 hours,
• cutaneous reactions were evaluated 1 hour after removal of the dressing.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1 intradermal exposure and 1 epicutaneous (occlusive) exposure
- Exposure period: intradermal on day 1, epicutaneous on day 9, Sodium lauryl Sulfate 10% on day 8
- Test groups: 10 males and 10 females
- Control group: no data
- Site: the interscapular region, same site for both induction exposures
- Frequency of applications: single treatment for both intradermal and epicutaneous exposures
- Duration: intradermal exposure: single injection, epicutaneous exposure: 48h under occlusive dressing
- Concentrations:
intradermally for induction: Freund's complete adjuvant (FCA) diluted at 50% (v/v) with 0.9% NaCl, 0.1% (w/w) test item in sterile olive oil and 0.1% test item in a mixture FCA/olive oil (50/50, v/v),
epicutaneous for induction: 1% (w/w) in sterile olive oil
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Two weeks after the induction phase
- Exposure duration: 24 h under occlusive dressing
- Test groups: 10 males and 10 females
- Control group: no data
- Concentrations: 1% (w/w) in sterile olive oil
- Evaluation (hr after challenge): 24 , 48 hours after removal of the dressing according to the method of Draize (See table 1 in results and discussion free-text for details)
GENERAL
- The animals were observed at least once a day during the study in order to check for clinical signs and mortality.
- The animals were weighed individually on the day 0, 7, 14, 21 and 28.
- Necropsy: on day 28 Cutaneous samples were taken (one from each flank) from the challenge application site of each animal microscopically examined. - Positive control substance(s):
- not specified
Results and discussion
- Positive control results:
- no data
Any other information on results incl. tables
PRELIMINARY STUDY:
- By intradermal route: Since the lowest concentration (1%) elicited a moderate erythema, it was decided to reduce the concentration to be applied at 0.1%. This concentration induced a very slight erythema.
- By cutaneous route: A very slight erythema was observed at 1%. This concentration was chosen for topical induction and for challenge.
MAIN STUDY:
- Clinical findings: Normal behaviour was observed in all animals, except in the two animals found dead, which were prostrated and diarrhoeicd before death.
- Mortality: Two males died: one on day 18, another on day 20.
- Body weight: No significant changes were observed in body weight gain.
- Necropsy: An epidermal densification (more or less marked) was found in 4 males and 5 females. These reactions are common in guinea-pigs and not significant. However, neither oedema nor sensitizing cellular features were observed.
- Scoring of cutaneous reactions: . At the end of induction period: Signs of irritation were observed on day 10 at the intradermal injection sites in control and treated groups. . After challenge application: Three males and five females exhibited a grade 1 (slight) erythema after 24h. This cutaneous reaction persisted in the same males and in only three females at the 48-hour examination time. No cutaneous reactions were observed in other animals.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the experimental conditions and according to the maximization method of Magnusson and Kligman, the test substance should not be considered as a skin sensitizer.
- Executive summary:
The sensitation potential of Amines, N-tallow alkyltrimethylenedi-, propoxylated was tested in male an female guinea Pigs according to the Magnusson Kligmann method (comparable to OECD 406).
The test item was found not to be sensitising.
10 male and 10 female Dunkin-Hartley guinea pigs were exposed to the test item following the classical Magnusson Kligmann test design.
Findings:
- Clinical findings: Normal behaviour was observed in all animals, except in the two animals found dead, which were prostrated and diarrhoeicd before death.
- Mortality: Two males died: one on day 18, another on day 20.
- Body weight: No significant changes were observed in body weight gain.
- Necropsy: An epidermal densification (more or less marked) was found in 4 males and 5 females. These reactions are common in guinea-pigs and not significant. However, neither oedema nor sensitizing cellular features were observed.
- Scoring of cutaneous reactions:
At the end of induction period: Signs of irritation were observed on day 10 at the intradermal injection sites in control and treated groups.
After challenge application: Three males and five females exhibited a grade 1 (slight) erythema after 24h. This cutaneous reaction persisted in the same males and in only three females at the 48-hour examination time. No cutaneous reactions were observed in other animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.